Abstract
Patients with chronic migraine headaches complicated by medication overuse (MO) present some of the most difficult treatment challenges for headache practitioners. Recent research has identified a variety of risk factors (including MO) that appear to be associated with the escalation of the frequency and severity of migraine headache. Management of such patients with medication overuse headaches (MOH) may become more problematic due to co-morbid psychiatric issues common with migraine patients and the patient’s reluctance to limit/eliminate “overused” abortive medications. Medication adherence becomes an important treatment concern. The present article will highlight treatment issues that must be considered in the assessment and treatment of patients with chronic migraine and MOH. Case examples will be offered to illustrate the process of the implementation of these strategies.
Similar content being viewed by others
References
Stewart WF, Lipton RB, Celentano DD et al (1992) Prevalence of migraine headache in the United States: relation to age, income, race, and other sociodemographic factors. JAMA 267:64–69
Lipton RB, Hamelsky SW, Stewart WF (2001) Epidemiology and impact of headache. In: Silberstein SD, Lipton RB, Dalessio DJ (eds) Wolff’s headaches and other head pain, 7th edn. Oxford University Press, Oxford, pp 85–107
Lipton RB, Hamelsky SW, Kolodner KB et al (2000) Migraine, quality of life, and depression: a population-based case-controlled study. Neurology 55:629–635
VonKorff M, Stewart WF, Simon DJ et al (1998) Migraine and reduced work performance: a population-based diary study. Neurology 50:1741–1745
Hu HX, Markson LE, Lipton RB et al (1999) Burden of migraine in the United States: disability and economic costs. Arch Intern Med 159:813–818
Lipton RB, Bigal ME (2007) Ten lessons in the epidemiology of migraine. Headache 47(Suppl 1):S2–S9
Bigal ME, Serrano D, Scher A et al (2008) Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48(Suppl 4):S3
Katsarava Z, Schneeweiss S, Kurth T et al (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62:788–790
Lipton RB, Buse D, Serrano D et al (2008) Differences in rates of common comorbid medical and psychiatric conditions in chronic and episodic migraine individuals. Headache 48(Suppl 4):S4
Ferrari A, Leone S, Vergoni AV et al (2007) Similarities and differences between chronic migraine and episodic migraine. Headache 47:65–72
Peterlin BL, Tietjen G, Meng S et al (2008) Post-traumatic stress disorder in episodic and chronic migraine. Headache 48:517–522
Rapoport A (2008) Medication overuse headache: awareness, detection, and treatment. CNS Drugs 22(12):995–1004
Cupini LM, Calabresi P (2005) Medication-overuse headache: pathophysiological insights. J Headache Pain 6:199–202
Diener HC, Limroth V (2004) Medication-overuse headache: a worldwide problem. Lancet 3:475–483
Colas R, Munoz P, Temprano R et al (2004) Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 62:1338–1342
International Classification of Disorders, Committee of the International Headache Society (2004) Classification and diagnostic criteria for headache disorders, cranial neuralgia, and facial pain. Cephalalgia 24(Suppl 1):1–150
Meskunas CA, Tepper SJ, Rapoport AM et al (2006) Medications associated with probable medication overuse headache reported in a tertiary care headache center reported over a 15-year period. Headache 46:766–772
Dodick D, Freitag F (2006) Evidence-based understanding of medication overuse headache: clinical implications. Headache 46(Suppl 4):S202–S211
Mathew NT, Kurman R, Perez F (1990) Drug-induced refractory headache-clinical features and management. Headache 30:634–638
Ward TN (2008) Drug-induced refractory headache. Headache 48:728–729
Mathew NT (1990) Drug-induced headache. Neurol Clin 8:903–912
Lake AE (2006) Medication overuse headache: biobehavioral issues and solutions. Headache 46(Suppl 3):S88–S97
Holroyd KA, O’Donnell FJ, Stensland M et al (2001) Management of chronic tension-type headache with tricyclic antidepressant medication, stress-management therapy, and their combination: a randomized controlled trial. JAMA 285:2208–2215
Grazzi L, Andrasik F, D’Amico D et al (2002) Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at three years. Headache 42:483–490
Rains JC, Lipchik GL, Penzien DB (2006) Behavioral facilitation of medical treatment for headache—part I: review of headache treatment compliance. Headache 46:1387–1394
Rains JC, Penzien DB, Lipchik GL (2006) Behavioral facilitation of medical treatment for headache—part II: theoretical models and behavioral strategies for improving adherence. Headache 46:1395–1403
Bigal ME, Lipton RB (2006) Modifiable risk factors for migraine progression. Headache 46:1334–1343
Lipton RB, Bigal ME, Diamond M et al (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:343–349
Nicholson R, Bigal M (2008) Screening and behavioral management: obesity and weight management. Headache 48:51–57
Bigal ME, Serrano D, Buse D et al (2008) Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48:1157–1168
Wilkinson SM, Becker WJ, Heine JA (2001) Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 41:303–309
Bahra A, Walsh M, Menon S et al (2003) Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 43:179–190
Paemeleire K, Bahra A, Evers S et al (2006) Medication-overuse headache in patients with cluster headache. Neurology 67:109–113
Rozen TD (2008) Migraine prevention: what patients want from medication and their physician. Headache 48:750–753
Spierings EL, Miree LF (1993) Non-compliance with follow-up and improvement after treatment at a headache center. Headache 33:205–209
Holroyd KA, Cordingley GE, Pingel JD et al (1989) Enhancing the effectiveness of abortive therapy: a controlled evaluation of self management training. Headache 29:148–153
Gallagher RM, Kunkel R (2003) Migraine medication attributes important for patient compliance: concerns about side effects could delay treatment. Headache 43:36–43
Mulleners WM, Whitmarsh TE, Steiner TJ (1998) Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better. Cephalalgia 18:52–56
Packard RC, Brown F (1986) Multiple headaches in a case of multiple personality disorder. Headache 26:99–102
Ng-Mak DS, Cady R, Chen Y et al (2007) Can migraineurs accurately identify their headaches as “migraine” at attack onset? Headache 47:645–653
Golden W, Katic BJ, Hu H (2008) Factors associated with early treatment of acute migraine headache pain. Headache 48(Suppl):S42–S43
Golden W, Katic BJ, Hu H (2008) Why did migraine patients not treat migraine attacks as early as they desired? Headache 48(Suppl):S42
Hamelsky SW, Lipton RB (2006) Psychiatric comorbidity of migraine. Headache 46:1327–1333
Low NCD, Merikangas KR (2003) The comorbidity of migraine. CNS Spectr 8:433–444
Breslau N, Lipton RB, Stewart WF et al (2003) Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 60:1308–1312
Conflict of interest statement
I certify that there is no actual or potential conflict of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weeks, R.E. Practical strategies for treating chronic migraine with medication overuse: case examples and role play demonstrations. Neurol Sci 30 (Suppl 1), 95–99 (2009). https://doi.org/10.1007/s10072-009-0080-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-009-0080-4